Ichnos Glenmark Innovation

Ichnos Glenmark Innovation (IGI) is an alliance between Ichnos Sciences Inc. (a globally fully integrated clinical-stage biotechnology company developing multispecific™ drugs for oncology) and Glenmark Pharmaceuticals Ltd., dedicated to rapidly advancing new cancer treatments through collaboration. The company focuses on creating cutting-edge solutions for treating hematologic malignancies and solid tumors. It is currently making pioneering progress in the field of oncology, enhancing the immune system's ability to detect and kill cancer.